Zhejiang Medicine Hits Day Low of CNY 13.22 Amid Price Pressure

Zhejiang Medicine Co., Ltd. experienced a significant decline today, with the stock dropping by 8.88% and reaching an intraday low of CNY 13.22. This performance stands in contrast to the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Zhejiang Medicine has seen a marginal decline of 0.75%, while its monthly performance remains positive at 7.91%. Despite the recent uptick, the stock has struggled over the past year, showing a decrease of 18.23%, significantly underperforming the market, which has returned 3.56% during the same period. Year-to-date, the stock is down 4.55%, while the broader index has declined by only 1.6%. Financially, Zhejiang Medicine has reported strong operating cash flow, reaching CNY 2,018.84 million, and maintains a healthy cash position of CNY 6,124.58 million. However, its long-term growth metrics indicate a slower pace, with net sales growing at an annual rate of 4.64% over the last five years. The company's return on equity stands at 12.47%, reflecting a valuation with a price-to-book ratio of 1.22.